The contents of this website are intended for US Healthcare Professionals only.
Indication
ZILBRYSQ® (zilucoplan) is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
Please enter your email.
Your password will be reset and a temporary password will be sent to the email address on file.
